Zoetis Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
447 / 1328
Position in country
3476 / 14179
Return on Assets, %
16.6
-2.7
Net income margin, %
23.6
2.8
EBITDA margin, %
38
10.8
Debt to Equity, %
131.4
19.2
Intangible assets and goodwill, %
28.6
3.6
Revenue CAGR 3Y, %
8.5
8.5
Total Equity change 1Y, %
13.4
0
Revenue Y, % chg
5.7
0.5
P/E
29.5
22.7
P/BV
13.7
1.5
P/S
8
2.3
EV/S
8.5
2.4
EV/EBITDA
20.3
7.4
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
49.3
51.3
Forward P/E
25
15.6
Dividend Yield, %
1.1
1.7
Forward Dividend Yield, %
1.1
0.2
Expected dividend per share
1.7
0
Payout Ratio, %
30.5
30.3
Dividend Ex Date
2024-04-18
Competitors
Ranks
-
Royalty Pharma PLC
00%
-
Zoetis Inc
00%
-
Eli Lilly and Co
00%
-
Bristol-Myers Squibb Co
00%
-
Elanco Animal Health Inc
00%
-
Johnson & Johnson
00%
-
Viatris Inc
00%
-
Merck & Co Inc
00%
-
Pfizer Inc
00%
-
Catalent Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
68670.9
Ticker
ZTS.N
ISIN
US98978V1035
IPO date
2013-02-01
Availability on Russian exchanges
Yes
Reporting for
2024-02-13
Date fact. publication of reports
2023-12-31
Company Description
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: